Nothing Special   »   [go: up one dir, main page]

Skip to main content

Advertisement

Log in

Chemopreventive role of probiotics against cancer: a comprehensive mechanistic review

  • Review
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Probiotics use different mechanisms such as intestinal barrier improvement, bacterial translocation and maintaining gut microbiota homeostasis to treat cancer. Probiotics’ ability to induce apoptosis against tumor cells makes them more effective to treat cancer. Moreover, probiotics stimulate immune function through an immunomodulation mechanism that induces an anti-tumor effect. There are different strains of probiotics, but the most important ones are lactic acid bacteria (LAB) having antagonistic and anti-mutagenic activities. Live and dead probiotics have anti-inflammatory, anti-proliferative, anti-oxidant and anti-metastatic properties which are useful to fight against different diseases, especially cancer. The main focus of this article is to review the anti-cancerous properties of probiotics and their role in the reduction of different types of cancer. However, further investigations are in progress to improve the efficiency of probiotics in cancer treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data Availability

Nearly all of the data collected during this study are incorporated in this article. However data in raw form are available from the corresponding author upon request.

Abbreviations

ALL:

Acute lymphocytic leukemia

AML:

Acute myeloid leukemia

BCG:

Bacillus galmette-guerin

CFU:

Colony forming unit

CRC:

Colorectal cancer

CTL:

Cytotoxic T lymphocytes

DCs:

Dendritic cells

EMT:

Epithelial–mesenchymal transition

EN:

Enteral nutrition

GC:

Gastric cancer

GIT:

Gastrointestinal tract

IL-10:

Interleukin-10

LAB:

Lactic acid bacteria

LGG:

Lactobacillus rhamnosus GG

MMP-9:

Matrix Metalloproteinase-9

NK cells:

Natural killer cells

TRAIL:

Tumor necrosis factor apoptosis-inducing ligand

UCC:

Urothelial cell carcinoma

UGIC:

Upper gastrointestinal cancer

UVC:

Ultraviolet C

VEGF:

Vascular endothelial growth factor

WHO:

World Health Organization

WT1:

Wilms’ tumor 1

XCL1:

Chemokine C motif ligand 1

References

  1. Ferlay J, Ervik M, Lam F et al (2020) Global cancer observatory: cancer today. International Agency for Research on Cancer, Lyon

    Google Scholar 

  2. Tripathy A, Dash J, Kancharla S et al (2021) Probiotics: a promising candidate for management of colorectal cancer. Cancers 13:3178

    Article  CAS  Google Scholar 

  3. Mutebi M, Dehar N, Nogueira LM, Shi K, Yabroff KR, Gyawali B (2022) Cancer groundshot: building a robust cancer control platform in addition to launching the cancer moonshot. Am Soc Clin Oncol Educ Book 42:1–16

    Google Scholar 

  4. Campbell BB, Light N, Fabrizio D et al (2017) Comprehensive analysis of hypermutation in human cancer. Cell 171:1042–1056

    Article  CAS  Google Scholar 

  5. Bedada TL, Feto TK, Awoke KS, Garedew AD, Yifat FT, Birri DJ (2020) Probiotics for cancer alternative prevention and treatment. Biomed Pharmacother 129:110409

    Article  Google Scholar 

  6. Biswas P, Pal S, Das M, Dam S (2022) Microbe-induced oxidative stress in cancer development and efficacy of probiotics as therapeutics in preventing its onset and progression. Handbook of oxidative stress in cancer: therapeutic aspects. Springer, Singapore. https://doi.org/10.1007/978-981-16-1247-3_159-1

    Chapter  Google Scholar 

  7. Hassan Z (2019) Anti-cancer and biotherapeutic potentials of probiotic bacteria. J Cancer Sci Ther 11:9–13

    Article  Google Scholar 

  8. Daniluk U (2012) Probiotics, the new approach for cancer prevention and/or potentialization of anti-cancer treatment. J Clin Exp Oncol 1:2

    Article  Google Scholar 

  9. Dasari S, Kathera C, Janardhan A, Kumar AP, Viswanath B (2017) Surfacing role of probiotics in cancer prophylaxis and therapy: a systematic review. Clin Nutr 36:1465–1472

    Article  Google Scholar 

  10. Nazir Y, Hussain SA, Abdul Hamid A, Song Y (2018) Probiotics and their potential preventive and therapeutic role for cancer, high serum cholesterol, and allergic and HIV diseases. BioMed Res Int 2018:3428437

    Article  Google Scholar 

  11. Heydari A, Parvini F, Fard NA (2022) Functional foods and antioxidant effects: emphasizing the role of probiotics; in functional food. IntechOpen, London

    Google Scholar 

  12. Chandel D, Sharma M, Chawla V, Sachdeva N, Shukla G (2019) Isolation, characterization and identification of antigenotoxic and anticancerous indigenous probiotics and their prophylactic potential in experimental colon carcinogenesis. Sci Rep 9:1–12

    Article  CAS  Google Scholar 

  13. Khan AA, Nema V, Khan Z (2021) Current status of probiotics for prevention and management of gastrointestinal cancers. Expert Opin Biol Ther 21:413–422

    Article  CAS  Google Scholar 

  14. Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA (2019) Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol 16:605–616

    Article  Google Scholar 

  15. Sankarapandian V, Venmathi Maran BA, Rajendran RL et al (2022) An update on the effectiveness of probiotics in the prevention and treatment of cancer. Life 12:59

    Article  CAS  Google Scholar 

  16. Thilakarathna WPW, Rupasinghe HV, Ridgway ND (2021) Mechanisms by which probiotic bacteria attenuate the risk of hepatocellular carcinoma. Int J Mol Sci 22:2606

    Article  Google Scholar 

  17. Uccello M, Malaguarnera G, Basile F et al (2012) Potential role of probiotics on colorectal cancer prevention. BMC Surg 12:1–8

    Article  Google Scholar 

  18. Lamichhane P, Maiolini M, Alnafoosi O et al (2020) Colorectal cancer and probiotics: are bugs really drugs? Cancers 12:1162

    Article  CAS  Google Scholar 

  19. Motevaseli E, Dianatpour A, Ghafouri-Fard S (2017) The role of probiotics in cancer treatment: emphasis on their in vivo and in vitro anti-metastatic effects. Int J Mol Cell Med 6:66

    Google Scholar 

  20. Kapoor B, Singh A, Gulati M et al (2022) Orchestration of obesolytic activity of microbiome: metabiotics at centre stage. Curr Drug Metab 23:90–98

    Article  Google Scholar 

  21. Prazdnova EV, Mazanko MS, Chistyakov VA et al (2022) Antimutagenic activity as a criterion of potential probiotic properties. Probiot Antimicrob Proteins. https://doi.org/10.1007/s12602-021-09870-9

    Article  Google Scholar 

  22. Salehi B, Dimitrijević M, Aleksić A et al (2021) Human microbiome and homeostasis: insights into the key role of prebiotics, probiotics, and symbiotics. Crit Rev Food Sci Nutr 61:1415–1428

    Article  CAS  Google Scholar 

  23. Chang C-J, Lin T-L, Tsai Y-L et al (2019) Next generation probiotics in disease amelioration. J food drug Anal 27:615–622

    Article  CAS  Google Scholar 

  24. O’Toole PW, Marchesi JR, Hill C (2017) Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat Microbiol 2:1–6

    Article  Google Scholar 

  25. Saber A, Alipour B, Faghfoori Z, Yari Khosroushahi A (2017) Cellular and molecular effects of yeast probiotics on cancer. Crit Rev Microbiol 43:96–115

    Article  Google Scholar 

  26. Kuczkowska K, Øverland L, Rocha SD, Eijsink VG, Mathiesen G (2019) Comparison of eight Lactobacillus species for delivery of surface-displayed mycobacterial antigen. Vaccine 37:6371–6379

    Article  CAS  Google Scholar 

  27. Batista VL, Da Silva TF, de Jesus LCL et al (2020) Probiotics, prebiotics, synbiotics, and paraprobiotics as a therapeutic alternative for intestinal mucositis. Front Microbiol 11:544490

    Article  Google Scholar 

  28. Şener D, Bulut HN, Güneş Bayir A (2021) Probiotics and relationship between probiotics and cancer types. Bezmialem Sci 9:490–497

    Article  Google Scholar 

  29. Tripathi MK, Giri SK (2014) Probiotic functional foods: survival of probiotics during processing and storage. J Funct Foods 9:225–241

    Article  CAS  Google Scholar 

  30. Shang X, E F-F, Guo K-L et al (2022) Effectiveness and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 randomized controlled trials. Nutrients 14:2482

    Article  Google Scholar 

  31. Georgieva M, Georgiev K, Hvarchanova N (2022) Probiotics: past, present, and future challenges. Probiotics in the prevention and management. Elsevier, Amsterdam, pp 431–448

    Google Scholar 

  32. Syiemlieh I, Morya S (2022) Dairy and non-dairy based probiotics: a review. Pharma Innov J 11:2956–2964

    Article  Google Scholar 

  33. Plaza-Diaz J, Ruiz-Ojeda F, Gil-Campos M, Gil A (2019) Mechanisms of action of probiotics. Adv Nutr 10:S49–S66

    Article  Google Scholar 

  34. Smith H (2022) Key facts about probiotics and antibiotics. S Afr Pharm Assist 22:20–22

    Google Scholar 

  35. Kerry RG, Patra JK, Gouda S, Park Y, Shin H-S, Das G (2018) Benefaction of probiotics for human health: a review. J food drug Anal 26:927–939

    Article  Google Scholar 

  36. Yadav M, Mandeep, Shukla P (2020) Probiotics of diverse origin and their therapeutic applications: a review. J Am Coll Nutr 39:469–479

    Article  CAS  Google Scholar 

  37. Hukins R, Krumbeck J, Bindels L et al (2016) Prebiotics: why definition matter. Curr Opin Biotechnol 37:1–7

    Article  Google Scholar 

  38. Yadav MK, Kumari I, Singh B, Sharma KK, Tiwari SK (2022) Probiotics, prebiotics and synbiotics: safe options for next-generation therapeutics. Appl Microbiol Biotechnol 106(2):505–521

    Article  CAS  Google Scholar 

  39. Chan MZA, Liu S-Q (2022) Fortifying foods with synbiotic and postbiotic preparations of the probiotic yeast, Saccharomyces boulardii. Curr Opin Food Sci 43:216–224

    Article  CAS  Google Scholar 

  40. Pandey K, Naik S, Vakil B (2015) Probiotics, prebiotics and synbiotics-a review. J Food Sci Technol 52:7577–7587

    Article  CAS  Google Scholar 

  41. Agah S, Alizadeh AM, Mosavi M et al (2019) More protection of Lactobacillus acidophilus than Bifidobacterium bifidum probiotics on azoxymethane-induced mouse colon cancer. Probiot Antimicrob Proteins 11:857–864

    Article  CAS  Google Scholar 

  42. Sharma A (2019) Importance of probiotics in cancer prevention and treatment. Recent developments in applied microbiology and biochemistry. Elsevier, Amsterdam, pp 33–45

    Chapter  Google Scholar 

  43. Górska A, Przystupski D, Niemczura MJ, Kulbacka J (2019) Probiotic bacteria: a promising tool in cancer prevention and therapy. Curr Microbiol 76:939–949

    Article  Google Scholar 

  44. Steidler L, Hans W, Schotte L et al (2000) Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289:1352–1355

    Article  CAS  Google Scholar 

  45. Del Carmen S, de LeBlanc AdM, Levit R et al (2017) Anti-cancer effect of lactic acid bacteria expressing antioxidant enzymes or IL-10 in a colorectal cancer mouse model. Int Immunopharmacol 42:122–129

    Article  Google Scholar 

  46. Wang Z, Yu Q, Gao J, Yang Q (2012) Mucosal and systemic immune responses induced by recombinant Lactobacillus spp. expressing the hemagglutinin of the avian influenza virus H5N1. Clin Vaccine Immunol 19:174–179

    Article  CAS  Google Scholar 

  47. Li Y, Li X, Liu H, Zhuang S, Yang J, Zhang F (2014) Intranasal immunization with recombinant Lactococci carrying human papillomavirus E7 protein and mouse interleukin–12 DNA induces E7–specific antitumor effects in C57BL/6 mice. Oncol Lett 7:576–582

    Article  Google Scholar 

  48. Kitagawa K, Oda T, Saito H et al (2017) Development of oral cancer vaccine using recombinant Bifidobacterium displaying Wilms’ tumor 1 protein. Cancer Immunol Immunother 66:787–798

    Article  CAS  Google Scholar 

  49. Sasaki T, Fujimori M, Hamaji Y et al (2006) Genetically engineered Bifidobacterium longum for tumor-targeting enzyme‐prodrug therapy of autochthonous mammary tumors in rats. Cancer Sci 97:649–657

    Article  CAS  Google Scholar 

  50. Wei C, Xun A, Wei X et al (2016) Bifidobacteria expressing tumstatin protein for antitumor therapy in tumor-bearing mice. Technol Cancer Res Treat 15:498–508

    Article  CAS  Google Scholar 

  51. Wang C, Ma Y, Hu Q et al (2016) Bifidobacterial recombinant thymidine kinase-ganciclovir gene therapy system induces FasL and TNFR2 mediated antitumor apoptosis in solid tumors. BMC Cancer 16:1–15

    Article  Google Scholar 

  52. Śliżewska K, Markowiak-Kopeć P, Śliżewska W (2020) The role of probiotics in cancer prevention. Cancers 13:20

    Article  Google Scholar 

  53. Prabhurajeshwar C, Chandrakanth K (2019) Evaluation of antimicrobial properties and their substances against pathogenic bacteria in-vitro by probiotic Lactobacilli strains isolated from commercial yoghurt. Clin Nutr Experimental 23:97–115

    Article  Google Scholar 

  54. Drago L (2019) Probiotics and colon cancer. Microorganisms 7:66

    Article  CAS  Google Scholar 

  55. Yu A-Q, Li L (2016) The potential role of probiotics in cancer prevention and treatment. Nutr Cancer 68:535–544

    Article  Google Scholar 

  56. Zhang L, Turner B, Ribbeck K, Ten Hagen KG (2017) Loss of the mucosal barrier alters the progenitor cell niche via Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling. J Biol Chem 292:21231–21242

    Article  CAS  Google Scholar 

  57. Liu Y, Tran DQ, Rhoads JM (2018) Probiotics in disease prevention and treatment. J Clin Pharmacol 58:S164–S179

    Article  CAS  Google Scholar 

  58. Yu Q, Yuan L, Deng J, Yang Q (2015) Lactobacillus protects the integrity of intestinal epithelial barrier damaged by pathogenic bacteria. Front Cell Infect Microbiol 5:26

    Article  Google Scholar 

  59. Badgeley A, Anwar H, Modi K, Murphy P, Lakshmikuttyamma A (2021) Effect of probiotics and gut microbiota on anti-cancer drugs: Mechanistic perspectives. Biochimica et Biophysica Acta (BBA) 1875:188494

    CAS  Google Scholar 

  60. Demers-Mathieu V, DaPra C, Medo E (2022) Influenza vaccine associated with the gene expression of T cell surface markers in human milk. Breastfeed Med 17:218–225

    Article  Google Scholar 

  61. Bajaj BK, Claes IJ, Lebeer S (2021) Funct Mech Probiot. Journal of microbiology, biotechnology and food sciences 2021:321–327

    Google Scholar 

  62. Plaza-Diaz J, Muñoz-Quezada S, Gomez-Llorente C, Gil A (2012) Probiotic mechanisms of action. Ann Nutr Metab 61:160–174

    Article  Google Scholar 

  63. Takeda K, Okumura K (2007) Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-cell activity. J Nutr 137:791S-793S

    Article  CAS  Google Scholar 

  64. Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y (2020) Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target therapy 5:1–17

    Article  Google Scholar 

  65. Pachmayr E, Treese C, Stein U (2017) Underlying mechanisms for distant metastasis-molecular biology. Visc Med 33:11–20

    Article  Google Scholar 

  66. Dillekås H, Rogers MS, Straume O (2019) Are 90% of deaths from cancer caused by metastases? Cancer Med 8:5574–5576

    Article  Google Scholar 

  67. Yang J, Antin P, Berx G et al (2020) Guidelines and definitions for research on epithelial–mesenchymal transition. Nat Rev Mol Cell Biol 21:341–352

    Article  Google Scholar 

  68. Hapach LA, Mosier JA, Wang W, Reinhart-King CA (2019) Engineered models to parse apart the metastatic cascade. NPJ Precis Oncol 3:1–8

    Google Scholar 

  69. Yue Y-C, Yang B-Y, Lu J et al (2020) Metabolite secretions of Lactobacillus plantarum YYC-3 may inhibit colon cancer cell metastasis by suppressing the VEGF-MMP2/9 signaling pathway. Microb Cell Fact 19:1–12

    Article  Google Scholar 

  70. Li X, Wang H, Du X et al (2017) Lactobacilli inhibit cervical cancer cell migration in vitro and reduce tumor burden in vivo through upregulation of E-cadherin. Oncol Rep 38:1561–1568

    Article  CAS  Google Scholar 

  71. Tiptiri-Kourpeti A, Spyridopoulou K, Santarmaki V et al (2016) Lactobacillus casei exerts anti-proliferative effects accompanied by apoptotic cell death and up-regulation of TRAIL in colon carcinoma cells. PLoS ONE 11:e0147960

    Article  Google Scholar 

  72. Jacouton E, Chain F, Sokol H, Langella P, Bermudez-Humaran LG (2017) Probiotic strain Lactobacillus casei BL23 prevents colitis-associated colorectal cancer. Front Immunol 8:1553

    Article  Google Scholar 

  73. Ghanavati R, Asadollahi P, Shapourabadi MB, Razavi S, Talebi M, Rohani M (2020) Inhibitory effects of Lactobacilli cocktail on HT-29 colon carcinoma cells growth and modulation of the Notch and Wnt/β-catenin signaling pathways. Microb Pathog 139:103829

    Article  CAS  Google Scholar 

  74. Kumar RS, Kanmani P, Yuvaraj N et al (2012) Lactobacillus plantarum AS1 isolated from south Indian fermented food Kallappam suppress 1, 2-dimethyl hydrazine (DMH)-induced colorectal cancer in male Wistar rats. Appl Biochem Biotechnol 166:620–631

    Article  CAS  Google Scholar 

  75. Maroof H, Hassan ZM, Mobarez AM, Mohamadabadi MA (2012) Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. J Clin Immunol 32:1353–1359

    Article  CAS  Google Scholar 

  76. Han KJ, Lee N-K, Park H, Paik H-D (2015) Anticancer and anti-inflammatory activity of probiotic Lactococcus lactis NK34. J Microbiol Biotechnol 25:1697–1701

    Article  Google Scholar 

  77. Tarrah A, Castilhos Jd, Rossi RC et al (2018) In vitro probiotic potential and anti-cancer activity of newly isolated folate-producing Streptococcus thermophilus strains. Front Microbiol 9:2214

    Article  Google Scholar 

  78. Lee HA, Kim H, Lee K-W, Park K-Y (2015) Dead nano-sized Lactobacillus plantarum inhibits azoxymethane/dextran sulfate sodium-induced colon cancer in Balb/c mice. J Med Food 18:1400–1405

    Article  CAS  Google Scholar 

  79. Maghsood F, Johari B, Rohani M, Madanchi H, Saltanatpour Z, Kadivar M (2020) Anti-proliferative and anti-metastatic potential of high molecular weight secretory molecules from probiotic Lactobacillus reuteri cell-free supernatant against human colon cancer stem-like cells (HT29-ShE). Int J Pept Res Ther 26:2619–2631

    Article  CAS  Google Scholar 

  80. Chung I-C, OuYang C-N, Yuan S-N et al (2019) Pretreatment with a heat-killed probiotic modulates the NLRP3 inflammasome and attenuates colitis-associated colorectal cancer in mice. Nutrients 11:516

    Article  CAS  Google Scholar 

  81. Noroozi E, Tebianian M, Taghizadeh M, Dadar M, Mojgani N (2021) Anticarcinogenic potential of probiotic, postbiotic metabolites and paraprobiotics on human cancer cells. In: probiotic bacteria and postbiotic metabolites role in animal and human health.  Springer, Cham pp 153–177

  82. Nouri Z, Karami F, Neyazi N et al (2016) Dual anti-metastatic and anti-proliferative activity assessment of two probiotics on HeLa and HT-29 cell lines. Cell J (Yakhteh) 18:127

    Google Scholar 

  83. Lenoir M, Del Carmen S, Cortes-Perez NG et al (2016) RETRACTED ARTICLE: Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer. J Gastroenterol 51:862–873

    Article  CAS  Google Scholar 

  84. Motevaseli E, Azam R, Akrami SM et al (2016) The effect of Lactobacillus crispatus and Lactobacillus rhamnosusculture supernatants on expression of autophagy genes and HPV E6 and E7 oncogenes in the HeLa cell line. Cell J (Yakhteh) 17:601

    Google Scholar 

  85. Kassayova M, Bobrov N, Strojný L et al (2016) Anticancer and immunomodulatory effects of Lactobacillus plantarum LS/07, inulin and melatonin in NMU-induced rat model of breast cancer. Anticancer Res 36:2719–2728

    CAS  Google Scholar 

  86. Goulet O (2015) Potential role of the intestinal microbiota in programming health and disease. Nutr Rev 73:32–40

    Article  Google Scholar 

  87. Shin R, Itoh Y, Kataoka M et al (2016) Anti-tumor activity of heat-killed Lactobacillus plantarum BF-LP284 on Meth-A tumor cells in BALB/c mice. Int J Food Sci Nutr 67:641–649

    Article  CAS  Google Scholar 

  88. Lee N-K, Son S-H, Jeon EB, Jung GH, Lee J-Y, Paik H-D (2015) The prophylactic effect of probiotic Bacillus polyfermenticus KU3 against cancer cells. J Funct Foods 14:513–518

    Article  CAS  Google Scholar 

  89. Irecta-Nájera CA, del Huizar-López R, Casas-Solís M, Castro-Félix J, Santerre A (2017) Protective effect of Lactobacillus casei on DMH-induced colon carcinogenesis in mice. Probiotics and antimicrobial proteins 9:163–171

    Article  Google Scholar 

  90. Li J, Sung CYJ, Lee N et al (2016) Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice. Proc Natl Acad Sci 113:E1306–E1315

    CAS  Google Scholar 

  91. Nami Y, Haghshenas B, Haghshenas M, Abdullah N, Yari Khosroushahi A (2015) The prophylactic effect of probiotic Enterococcus lactis IW5 against different human cancer cells. Front Microbiol 6:1317

    Article  Google Scholar 

  92. Sivan A, Corrales L, Hubert N et al (2015) Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy. Science 350:1084–1089

    Article  CAS  Google Scholar 

  93. Wu Z, Wang G, Pan D et al (2016) Inflammation-related pro-apoptotic activity of exopolysaccharides isolated from Lactococcus lactis subsp. lactis. Benefic Microbes 7:761–768

    Article  CAS  Google Scholar 

  94. Tuo Y, Jiang S, Qian F et al (2015) Antiproliferative effect of 8 different Lactobacillus strains on K562 cells. J Dairy Sci 98:106–110

    Article  CAS  Google Scholar 

  95. Januszewicz W, Witczak K, Wieszczy P et al (2022) Prevalence and risk factors of upper gastrointestinal cancers missed during endoscopy: a nationwide registry-based study. Endoscopy 54:653–660

    Article  Google Scholar 

  96. Javanmard A, Ashtari S, Sabet B et al (2018) Probiotics and their role in gastrointestinal cancers prevention and treatment; an overview. Gastroenterol Hepatol Bed Bench 11:284

    Google Scholar 

  97. Yang J, Yang H, Li Y (2022) The triple interactions between gut microbiota, mycobiota and host immunity. Crit Rev Food Sci Nutr 1:1–21

    Google Scholar 

  98. Sotelo S, Manterola C, Otzen T, Morales E, Castillo I (2022) Prevalence of gastric preneoplastic lesions in first-degree relatives of patients with gastric cancer: a cross-sectional study. J Gastrointest Cancer 1–7

  99. He F-J, Wang M-J, Yang K et al (2022) Effects of preoperative oral nutritional supplements on improving postoperative early enteral feeding intolerance and short-term prognosis for gastric cancer: a prospective, single-center, single-blind, randomized controlled trial. Nutrients 14:1472

    Article  CAS  Google Scholar 

  100. Zhu XY, Liu F (2017) Probiotics as an adjuvant treatment in Helicobacter pylori eradication therapy. J Dig Dis 18:195–202

    Article  Google Scholar 

  101. Bajic P, Wolfe AJ, Gupta GN (2019) The urinary microbiome: implications in bladder cancer pathogenesis and therapeutics. Urology 126:10–15

    Article  Google Scholar 

  102. Min K, Kim HT, Lee EH, Park H, Ha Y-S (2022) Bacteria for treatment: microbiome in bladder cancer. Biomedicines 10:1783

    Article  CAS  Google Scholar 

  103. Sangar S, Cheng MW, Yu Y (2022) Probiotics for the treatment of other skin conditions (acne, psoriasis, seborrheic dermatitis, wounds, and skin cancer). Probiotics in the Prevention and Management of Human Diseases, pp 129–137

  104. Güneş Bayir A, Sener D, Bulut HN (2021) Probiotics and relationship between probiotics and cancer types

  105. Gunduz M, Murakami D, Gunduz I et al (2018) Recurrent bacterial translocation from gut and sepsis in Head and neck cancer patients and its prevention by probiotics. Med Hypotheses 120:124–127

    Article  CAS  Google Scholar 

  106. Doppalapudi R, Vundavalli S, Prabhat M (2020) Effect of probiotic bacteria on oral Candida in head-and neck-radiotherapy patients: A randomized clinical trial. J Cancer Res Ther 16:470

    Article  CAS  Google Scholar 

  107. Kumar SS (2022) Can probiotics stop oral cancer progression? Evid-Based Dent 23:22–23

    Article  Google Scholar 

  108. Mishra S, Rath S, Mohanty N (2020) Probiotics—A complete oral healthcare package. J Integr Med 18:462–469

    Article  Google Scholar 

  109. Carretta MD, Quiroga J, López R, Hidalgo MA, Burgos RA (2021) Participation of short-chain fatty acids and their receptors in gut inflammation and colon cancer. Front Physiol 12:662739

    Article  Google Scholar 

  110. Sivamaruthi BS, Kesika P, Chaiyasut C (2020) The role of probiotics in colorectal cancer management. Evidence-Based Complementary and Alternative Medicine 2020

  111. Sambrani R, Abdolalizadeh J, Kohan L, Jafari B (2021) Recent advances in the application of probiotic yeasts, particularly Saccharomyces, as an adjuvant therapy in the management of cancer with focus on colorectal cancer. Mol Biol Rep 48:951–960

    Article  CAS  Google Scholar 

  112. Liu A, Ma T, Xu N et al (2021) Adjunctive probiotics alleviates asthmatic symptoms via modulating the gut microbiome and serum metabolome. Microbiol Spectr 9:e00859–e00821

    Article  CAS  Google Scholar 

  113. Sehrawat N, Yadav M, Singh M, Kumar V, Sharma VR, Sharma AK (2021) Probiotics in microbiome ecological balance providing a therapeutic window against cancer

  114. Liu Z, Li C, Huang M et al (2015) Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: a double-center and double-blind randomized clinical trial. BMC Gastroenterol 15:1–14

    Article  Google Scholar 

  115. Ambalam P, Raman M, Purama RK, Doble M (2016) Probiotics, prebiotics and colorectal cancer prevention. Best Pract Res Clin Gastroenterol 30:119–131

    Article  Google Scholar 

  116. Hassan Z, Mustafa S, Rahim RA, Isa NM (2016) Anti-breast cancer effects of live, heat-killed and cytoplasmic fractions of Enterococcus faecalis and Staphylococcus hominis isolated from human breast milk. Vitro Cell Dev Biology-Animal 52:337–348

    Article  Google Scholar 

  117. Ranjbar S, Seyednejad SA, Zakeri SE, Rezaeizadeh H, Rahimi R (2021) Probiotics for prophylaxis and management of breast cancer: Preclinical and clinical evidence; in Probiotic Research in Therapeutics 159–189, Springer

  118. Onur E, Gökmen GG, Nalbantsoy A, Kışla D (2022) Investigation of the supportive therapy potential of propolis extract and Lactobacillus acidophilus LA-5 milk combination against breast cancer in mice. Cytokine 149:155743

    Article  CAS  Google Scholar 

  119. Liakina V, Strainienė S, Stundienė I, Maksimaitytė V, Kazėnaitė E (2022) Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis. World J Hepatol 17:1277–1290

    Article  Google Scholar 

  120. Meng C, Bai C, Brown TD, Hood LE, Tian Q (2018) Human gut microbiota and gastrointestinal cancer. Genom Proteom Bioinform 16:33–49

    Article  Google Scholar 

  121. Li S, Han W, He Q, Zhang W, Zhang Y (2022) Relationship between Intestinal Microflora and Hepatocellular Cancer Based on Gut-Liver Axis Theory. Contrast Media & Molecular Imaging 2022

  122. So SS, Wan ML, El-Nezami H (2017) Probiotics-mediated suppression of cancer. Curr Opin Oncol 29:62–72

    Article  Google Scholar 

  123. Hirsch FR, Scagliotti GV, Mulshine JL et al (2017) Lung cancer: current therapies and new targeted treatments. The Lancet 389:299–311

    Article  CAS  Google Scholar 

  124. Bradbury P, Sivajohanathan D, Chan A, Kulkarni S, Ung Y, Ellis PM (2017) Postoperative adjuvant systemic therapy in completely resected non–small-cell lung cancer: a systematic review. Clin Lung Cancer 18:259–273 e258

    Article  Google Scholar 

  125. Tian Y, Li M, Song W, Jiang R, Li YQ (2019) Effects of probiotics on chemotherapy in patients with lung cancer. Oncol Lett 17:2836–2848

    CAS  Google Scholar 

  126. Sharma A, Viswanath B, Park Y-S (2018) Role of probiotics in the management of lung cancer and related diseases: An update. J Funct Foods 40:625–633

    Article  Google Scholar 

  127. Cascardi E, Cazzato G, Daniele A et al (2022) Association between Cervical Microbiota and HPV: Could This Be the Key to Complete Cervical. Cancer Eradication? Biology 11:1114

    CAS  Google Scholar 

  128. Seyyedi Z, Parchebafi A, Kashani HH (2022) The microbiota, secondary metabolites and diseases: a putative role of probiotics in prevention and treatment of cancers

  129. Wen Y, Jin R, Chen H (2019) Interactions between gut microbiota and acute childhood leukemia. Front Microbiol 10:1300

    Article  Google Scholar 

  130. Kheyrandish S, Rastgar A, Hamidi M, Sajjadi SM, Sarab GA (2022) Evaluation of anti-tumor effect of the exopolysaccharide from new cold-adapted yeast, Rhodotorula mucilaginosa sp. GUMS16 on chronic myeloid leukemia K562 cell line. Int J Biol Macromol 206:21–28

    Article  CAS  Google Scholar 

  131. Hai Y, Hong Y, Yang Y (2022) miR-1258 Enhances the Anti-Tumor Effect of Liver Cancer Natural Killer (NK) Cells by Stimulating Toll-Liker Receptor (TLR) 7/8 to Promote Natural Killer (NK)-Dendritic Cell (DC) Interaction. J Biomaterials Tissue Eng 12:1241–1246

    Article  Google Scholar 

Download references

Acknowledgements

For the current study authors are extremely obliged to the Department of Zoology, Govt. College University, Lahore, Pakistan, for provision of research facilities.

Funding

Funding was not available for this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shaukat Ali.

Ethics declarations

Ethical approval

This article does not contain any studies with human participants or animals accomplished by any of the authors.

Consent to participate

Not applicable.

Informed consent

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declared no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 14.1 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Noor, S., Ali, S., Riaz, S. et al. Chemopreventive role of probiotics against cancer: a comprehensive mechanistic review. Mol Biol Rep 50, 799–814 (2023). https://doi.org/10.1007/s11033-022-08023-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-022-08023-7

Keywords

Navigation